Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07863193RecruitingPhase 3
Denifanstat for moderate to severe acne
This trial tests an experimental pill called denifanstat to see if it can clear up moderate to severe acne. If you qualify, you may receive the study drug or a placebo, and researchers will check how well it works on your skin over time.
Bryant, ArkansasAges 12 years+ - NCT07699471RecruitingPhase 3
Study of a new drug for adults with low parathyroid hormone
This trial tests an experimental drug called Canvuparatide against a placebo to see if it can help adults with a condition called hypoparathyroidism, where the body doesn't make enough parathyroid hormone. The goal is to improve calcium levels and reduce the need for high-dose calcium and vitamin D supplements.
Englewood, ColoradoAges 18 years+ - NCT06930625RecruitingPhase 3
Study of Debio 4126 for acromegaly patients on current therapy
This trial tests a new medication, Debio 4126, for people with acromegaly who are already being treated with octreotide or lanreotide. The goal is to see if it can help control hormone levels and is safe to use.
Los Angeles, CaliforniaAges 18 years+ - NCT07659782RecruitingPhase 2
Study of VS-7375 for KRAS G12D lung cancer
This trial tests a new drug, VS-7375, for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12D. It's for those who have already tried chemo and immunotherapy, and whose cancer has continued to grow.
Scottsdale, ArizonaAges 18 years+ - NCT07133633RecruitingPhase 2
Tulisokibart for X-ray confirmed axial spondyloarthritis
This study tests a new medicine called Tulisokibart for people with a type of inflammatory arthritis that affects the spine and pelvic joints, specifically when X-rays show changes. The goal is to see if it can reduce symptoms like pain and stiffness.
Chandler, ArizonaAges 18–80 - NCT07775313Enrolling by invitationPhase 1/Phase 2
Gene therapy for WHIM syndrome
This trial tests a one-time gene therapy treatment for WHIM syndrome, a rare immune disorder. It aims to fix the genetic cause to improve your body's ability to fight infections. Your stem cells will be collected, edited in a lab, and given back to you after some chemotherapy to prepare your body.
Bethesda, MarylandAges 3–75 - NCT07570979RecruitingPhase 1
Testing INR731 for Metastatic Prostate Cancer
This trial tests a new drug called INR731, given by mouth, for men with prostate cancer that has spread to other parts of the body. The study will check if the drug is safe and how well it works, either alone or combined with other prostate cancer medicines.
Boston, MassachusettsAges 18 years+ - NCT06270719Enrolling by invitation
Comparing ELEVIDYS to standard care for Duchenne muscular dystrophy
This study compares the gene therapy ELEVIDYS (delandistrogene moxeparvovec) to usual treatments for people with Duchenne muscular dystrophy (DMD). It helps researchers understand how well ELEVIDYS works over time in real-world settings.
Birmingham, AlabamaAges 4 years+ - NCT06561386RecruitingPhase 3
Testing a new drug combo for advanced lung cancer
This trial is comparing a new combination of two immunotherapy drugs (nivolumab and relatlimab) plus chemotherapy against the standard immunotherapy (pembrolizumab) plus chemotherapy for people with advanced non-squamous non-small cell lung cancer that has a certain protein (PD-L1) on at least 1% of its cells. The goal is to see if the new combination works better.
Mobile, AlabamaAges 18 years+ - NCT07888517Recruiting
Selumetinib for adults with NF1 and inoperable plexiform neurofibromas
This study looks at how well the drug selumetinib works and how safe it is in adults with Neurofibromatosis Type 1 (NF1) who have a plexiform neurofibroma that causes symptoms and can't be removed by surgery. Participants will continue their planned treatment with selumetinib, and researchers will monitor their progress.
BeijingAges 18 years+ - NCT07889219Recruiting
Long-term immunity after hepatitis A vaccine
This study checks how long the protection from a hepatitis A vaccine lasts in healthy people who got the full vaccine series years ago. It involves a blood test to measure immunity, which can help confirm if a booster is needed.
Changzhou, JiangsuAges 21–28 - NCT07889492RecruitingPhase 2
Testing a new medicine for vitiligo (white patches on skin)
This study tests an experimental medicine (called EB06) to see if it can help bring back skin color in people with vitiligo. If you join, you'll either get the medicine or a dummy pill, and the study will track your progress over about 6 months.
Edmonton, AlbertaAges 18 years+ - NCT07457918RecruitingPhase 3
Long-term safety and effectiveness of cantharidin for common warts
This study checks the long-term safety and how well a treatment using cantharidin (a substance from blister beetles) works for people who already took part in the previous study for common warts. The treatment is applied to the warts, and you'll be followed up over time.
Saint Augustine, FloridaAges 2 years+ - NCT07725523RecruitingPhase 2/Phase 3
New imaging agent to guide prostate cancer surgery
This trial tests a new imaging agent (OTL78) that helps surgeons see prostate cancer cells during prostate removal surgery. It aims to improve the precision of the surgery and potentially reduce the chance of leaving cancer behind.
Carmel, IndianaAges 18 years+ - NCT07888543Recruiting
Brain changes and heart rhythm in hard-to-treat epilepsy
This study looks at whether changes in a part of the brain (the hypothalamus) are linked to heart rate problems in people with epilepsy that doesn't improve with medication. The results might help doctors better understand and care for people with difficult-to-control seizures.
Amiens, PicardieAges 18 years+ - NCT07058155RecruitingPhase 4
Weight-loss surgery after TIPS for cirrhosis with high blood pressure in liver
This study tests whether doing weight-loss surgery after a TIPS procedure (which lowers pressure in the liver's blood vessels) is safe and helps people with cirrhosis and severe obesity. It might improve liver health and quality of life.
Cleveland, OhioAges 18–70 - NCT07768449Recruiting
Counseling support for older cancer survivors
This study offers counseling sessions by phone or video call to help cancer survivors aged 65 and older who have finished treatment or have no signs of cancer. The goal is to see if this support improves emotional well-being.
Basking Ridge, New JerseyAges 65 years+ - NCT07889999Recruiting
Ursosan for liver fat in Kazakhstan
This study looks at how well Ursosan, a medicine for liver problems, works in people with fatty liver disease linked to metabolic issues like obesity or diabetes. It may help improve liver health and reduce fat in the liver.
Aktobe, AktobeAges 18–65 - NCT07689682Recruiting
Brain wave scans for children with immune or other neurological diseases
This study uses a non-invasive brain scan called MEG to look at brain activity in children with neurological conditions, such as autoimmune encephalitis, multiple sclerosis, or stroke. It aims to better understand these diseases and could help improve future treatments.
Birmingham, West MidlandsAges 2–16 - NCT07890896Recruiting
Comparing phone and in-person counselling for women with depression or anxiety
This study compares two ways of providing counselling to women with depression or anxiety in Bangladesh: one over the phone and one in person. Participants will be randomly assigned to one of the two approaches to see which helps more.
Chāndpur, Matlab DakshinAges 18 years+ - NCT07888114RecruitingPhase 1
Study of entinostat for pediatric sarcoma with PAX gene changes
This trial tests an investigational drug called entinostat for children with a rare type of soft tissue sarcoma that has a specific gene change (PAX). The goal is to see if the drug can help shrink or control the tumor, either alone or combined with other treatments.
Beijing, Beijing MunicipalityAges 1–18 - NCT07890298RecruitingPhase 2
New medicine for opening blocked arteries after severe stroke
This study tests a new medicine called LT3001 for people who had a recent severe stroke caused by a blocked artery in the brain. It aims to reopen the blocked vessel and improve recovery, and is given within 24 hours of symptom onset without standard clot-busting treatment.
TaichungAges 18–88 - NCT07162415Recruiting
Ganglion removal for wrist pain
This trial tests whether removing a wrist ganglion cyst through surgery reduces pain better than other treatments. It aims to help people whose wrist pain is caused by this cyst.
HelsinkiAges 18 years+ - NCT07887971RecruitingPhase 1
Study of an experimental radiation drug for certain solid tumors
This trial tests an experimental drug that delivers radiation directly to cancer cells in people with certain advanced solid tumors. It may help shrink tumors or slow their growth in patients who have not responded to other treatments.
Miami, FloridaAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.